10.1089/scd.2014.0408 35
It may thus be suggested that direct exposure of the gut to the microbiome - capable of synthesizing thiamine antagonists or possessing thiamine-degrading thiaminase II - may first of all affect the gut, leading to gastrointestinal beriberi, especially under conditions of SIBO or other disturbances of the gut microbiome
as shown in experimental studies using cerebellar granular cell cultures exposed to glutamate after being treated with riboflavin or pyridoxine (82, 83)
Unlike larger therapeutic proteins, peptides are smaller and often break down faster in the digestive system, which is why many are administered through Peptide injections
In several RCTs, GLP-1RAs, when used alone or in combination with other hypoglycemic agents including metformin, sulfonylurea, DPP-4 inhibitor, thiazolidinedione, and sodium-glucose cotransporter 2 inhibitor, showed superior or non-inferior blood glucose lowering ability compared to insulin treatment [64,65]
The other is the tryptophan/tryptamine/serotonin/5-methoxytryptamine/melatonin pathway, which may be activated when plants produce substantial amounts of serotonin, such as during senescence (176, 177)
